This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Rickard Forsblom: Innovator in Pharmaceutical Chemistry
Introduction
Rickard Forsblom is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for medical treatments. His work focuses on innovative solutions for addressing complex health issues.
Latest Patents
Forsblom holds a patent for "Dihydropyridopyrimidines for the treatment of AB-related pathologies." This patent includes dihydropyridopyrimidine compounds of formula (Ia) and therapeutically acceptable salts thereof. The compounds are designed to target and treat Aβ-related pathologies, showcasing Forsblom's commitment to advancing medical science.
Career Highlights
Rickard Forsblom is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts.
Collaborations
Forsblom has worked alongside talented colleagues, including Didier Rotticci and Ellen Santangelo. These collaborations enhance the innovative potential of his projects and foster a dynamic research environment.
Conclusion
Rickard Forsblom's contributions to pharmaceutical chemistry and his innovative patent demonstrate his dedication to improving healthcare solutions. His work continues to impact the field positively, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile